Gyeonggi-do, South Korea

Jiknyeo Kim

This inventor holds 1 USPTO granted patent. Top assignee: Jw Pharmaceutical Corporation. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jiknyeo Kim. Retrieved from https://idiyas.com/inventor/jiknyeo-kim

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 11.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Jiknyeo Kim: Innovator in Hair Loss Therapy

Introduction

Jiknyeo Kim is a prominent inventor based in Gyeonggi-do, South Korea. He has made significant contributions to the field of pharmaceutical innovations, particularly in therapies for hair loss. His work is characterized by a commitment to developing effective solutions for conditions such as androgenic alopecia and alopecia areata.

Latest Patents

Jiknyeo Kim holds 1 patent for a novel heterocycle derivative. This invention relates to a unique heterocycle derivative, its salts, or isomers, which are effective in preventing hair loss. The composition he developed serves as an effective ingredient for the prevention of hair loss, showcasing his dedication to addressing this common issue.

Career Highlights

Currently, Jiknyeo Kim is associated with Jw Pharmaceutical Corporation, where he continues to innovate and contribute to the pharmaceutical industry. His work has garnered attention for its potential impact on hair loss therapies, making him a notable figure in this specialized field.

Collaborations

Throughout his career, Jiknyeo Kim has collaborated with esteemed colleagues, including Woo Sang Hong and Joo Young Cha. These partnerships have further enhanced his research and development efforts, leading to advancements in therapeutic solutions.

Conclusion

Jiknyeo Kim's contributions to the field of hair loss therapy through his innovative patent demonstrate his expertise and commitment to improving patient outcomes. His work continues to inspire advancements in pharmaceutical research and development.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…